FIELD: chemistry; pharmaceutics.
SUBSTANCE: invention relates to conjugates of amatoxin and a target-binding fragment, for example an antibody bound by certain bonds, which are applicable in treating cancer and other disorders and diseases. In a further aspect, the invention refers to pharmaceutical compositions containing such conjugates.
EFFECT: amatoxin derivatives are disclosed.
17 cl, 7 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMATOXIN CONJUGATES WITH IMPROVED BONDS | 2012 |
|
RU2575854C2 |
| AMATHOXINE-ANTIBODY CONJUGATES | 2016 |
|
RU2724328C2 |
| AMATOXIN-CONJUGATES WITH IMPROVED LINKERS | 2011 |
|
RU2601411C2 |
| NEW METHOD FOR SYNTHESIS OF AMANITINES | 2018 |
|
RU2792210C2 |
| CONJUGATE OF ANTIBODY WITH AMATOXIN OF NON-NATURAL TYPE | 2018 |
|
RU2840926C2 |
| ANTIBODY CONJUGATE WITH NON-NATURAL AMATOXIN | 2018 |
|
RU2798981C2 |
| SYNTHESIS OF (S)-6-HYDROXYTRYPTOPHANE AND ITS DERIVATIVES | 2019 |
|
RU2810786C2 |
| ANTIBODY DRUG CONJUGATES | 2014 |
|
RU2669812C2 |
| MATERIALS AND METHODS ASSOCIATED WITH LINKERS FOR USE IN DRUG AND PROTEIN CONJUGATES | 2015 |
|
RU2737553C2 |
| IMPROVED POLYETHYLENIMINE POLYETHYLENE GLYCOL VECTORS | 2015 |
|
RU2771104C2 |
